Skip to Content
Top

BY Brette Peyton

MD Anderson Cancer Center welcomes Peter WT Pisters, M.D., as the 76-year-old institution’s fifth full-time president. Pisters was officially named to the post in September after being unanimously selected as the sole finalist by the UT System Board of Regents. The renowned cancer surgeon, researcher, professor and administrator previously served MD Anderson in faculty and leadership roles for more than 20 years. Most recently, he...

Peter WT Pisters

BY Lany Kimmons

In recognition of their contributions to basic, translational, and clinical research, six faculty members from MD Anderson Cancer Center have...

BY Clayton Boldt, Ph.D.

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used...

BY Clayton Boldt, Ph.D.

The addition of ribociclib, an inhibitor of the cell cycle, to standard hormone therapy significantly improved progression-free survival (PFS) in pre-menopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at MD Anderson.

The trial results, presented at the 2017 San Antonio Breast Cancer Symposium by...

BY Clayton Boldt, Ph.D.

In a randomized, Phase III trial led by MD Anderson researchers, the PARP inhibitor talazoparib extended progression-free survival (PFS) and...

BY Ron Gilmore

Researchers from MD Anderson Cancer Center presented their latest findings involving drug treatments for blood cancers at the American...

BY Scott Merville

A targeted therapy resurrected by the Moon Shots Program™ at MD Anderson has produced unprecedented response rates among patients with metastatic...

BY Scott Merville

A major national effort to expand the reach of cancer immunotherapy in order to benefit more patients will draw upon the expertise...

BY Kathryn Boom

In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.

Having spent the...

BY Scott Merville

Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest types of the disease to defeat. A Dream Team...

BY Clayton Boldt, Ph.D.

It's been five years since MD Anderson launched its Moon Shots Program™, a collaborative effort to more quickly turn scientific discoveries...

BY Ronda Wendler

The effectiveness of opioids in treating cancer pain has been well established over the years. But today’s opioid epidemic that began slowly...

BY Scott Merville

V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery of selective...

BY Katrina Burton

Pediatric cancer patients who eat a healthy diet and exercise regularly may experience fewer cancer treatment side effects later in life,...

BY MD Anderson staff

Patients with stage zero breast cancer, also known as ductal carcinoma in situ, who undergo breast-conserving surgery that results in narrow...

BY Bryan Tutt

Recently approved targeted and immunotherapy drugs are helping patients diagnosed with follicular lymphoma live longer. Knowing the available...

BY Ronda Wendler

When Craig Bunk began experiencing severe abdominal pain, blood loss and fatigue, his family doctor thought a stomach ulcer was to blame....

BY Clayton R. Boldt, Ph.D.

Cancer is the second leading cause of death in the U.S., and will claim the lives of an estimated 600,920 in this country in 2017, according...

BY Lany Kimmons

Practicing Tibetan yoga twice a week may reduce sleep disturbances and improve sleep quality for breast cancer patients receiving chemotherapy...

BY Clayton R. Boldt, Ph.D.

Despite significant advances in lung cancer treatment, new approaches for early detection and prevention remain limited because the earliest...

BY Scott Merville

Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge...

BY Scott Merville

Nationally, only about 9% of people diagnosed with pancreatic cancer survive five years. In most cases, the disease has spread to other organs...

BY Ron Gilmore

Tomas Sandoval was about to become a father for the second time in June 2014, when he was devastated to learn he had non-Hodgkin lymphoma...

BY MD Anderson staff

Hurricane Harvey brought with it unprecedented rainfall – 27 trillion gallons – and staggering destruction – 33 Texas counties declared federal...

BY Clayton Boldt, Ph.D.

As teachers across the country prepare for a new school year, it is now easier than ever to make sun safety a part of daily lesson plans with...

BY Ron Gilmore

An MD Anderson study may help researchers predict which patients with non-small cell lung cancer will respond to checkpoint blockade therapy...

BY Ron Gilmore

Patterns in how genes express themselves may help doctors personalize treatment for glioblastoma, the most deadly of brain cancers, according...

BY Katrina Burton

The treatment of osteosarcoma, the most common tumor of bone, is challenging. An MD Anderson study found a drug known as bone metastasis-targeting...

BY Ron Gilmore

A study of high-grade ovarian cancer has shown the enzyme protein kinase C iota (PRKCI) to be an ovarian oncogene, suggesting PRKCI inhibition...

BY Clayton Boldt, Ph.D.

This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the University...

BY Julie Penne

MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...

BY Laura Sussman

For patients with advanced, inoperable stage 3 lung cancer, chemotherapy and a specialized form of radiation treatment known as proton...

BY Clayton Boldt, Ph.D.

Since 2006, MD Anderson’s Tobacco Treatment Program (TTP) has been providing tobacco cessation services to patients and employees seeking...

BY Scott Merville

A practice-changing clinical trial conceived and led by MD Anderson investigators showed that metastatic colorectal cancer patients with a...

BY Ron Gilmore

Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating pancreatic...

BY Ron Gilmore

Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been the inability to predict who will respond to standard...

BY Laura Sussman

High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients who have...

BY Ron Gilmore

A study at MD Anderson Cancer Center has shown promise for effective treatment of therapy-resistant cancers caused by a mutation...

BY Scott Merville

Researchers at MD Anderson Cancer Center have found that the blend of bacteria in the digestive tract of metastatic melanoma patients is associated...

BY Scott Merville

Natural killer cells sound menacing, but they play a friendly role in keeping us healthy. And they might do much more in stopping...

BY Ronda Wendler

When Jo Ann West learned she had early-stage breast cancer, her doctor suggested an inventive new treatment that involves no major surgery...

BY Scott Merville

After all 13 breast cancer patients in a first-of-its-kind clinical trial responded positively to a new targeted therapy, MD Anderson researchers...

BY Clayton Boldt, Ph.D.

Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as much as...

BY Sarah Bronson

Two new clinical trials at MD Anderson are taking aim at mantle cell lymphoma – a rare form of non-Hodgkin’s lymphoma.

Most mantle...

BY Ron Gilmore

What if you or a loved one had cancer but were denied access to a research study testing a poten-tially beneficial treatment?

This...

BY Ron Gilmore

There are many moving parts when it comes to the mechanics of how otherwise healthy cells are transformed into those that cause deadly cancers...

BY Clayton Boldt, Ph.D.

More than 50 years after the U.S. Surgeon General first warned about the dangers of cigarettes, smoking rates have plummeted.

BY Scott Merville

For decades, combination chemotherapy has been the main treatment for patients with acute myeloid leukemia (AML) – an aggressive cancer of...

BY Scott Merville

New initiatives to improve the treatment of pancreatic cancer have earned two early-career investigators at MD Anderson multi-year support...

BY Scott Merville

MD Anderson Chair of Immunology Jim Allison, Ph.D., whose pivotal work to attack cancer by treating the immune system instead of...

BY Clayton Boldt, Ph.D.

The American Dental Association (ADA) and MD Anderson Cancer Center have announced a joint effort to improve patient outcomes...

BY Sarah Watson

Eight MD Anderson researchers have been named 2017 Andrew Sabin Family Fellows. The Andrew Sabin Family Fellowship Program provides $100,000...

BY Ron Gilmore

Guillermina Lozano, Ph.D., chair of Genetics at MD Anderson, is one of 84 new members and 21 foreign associates elected to the National...

BY Bryan Tutt

Cancer patients who have undergone lymph node removal or radiation therapy as part of cancer treatment know all too well the pain and discomfort...

BY Clayton Boldt, Ph.D.

Select breast cancer patients who after undergoing chemotherapy as their first line of treatment show no residual cancer – a state known as...

BY MD Anderson staff

A number of MD Anderson physicians and scientists chaired or co-chaired sessions and presented research, ranging from racial disparities in...

BY Clayton Boldt, Ph.D.

This year, for the first time in Texas, lawmakers have proposed legislation that would raise the state’s minimum legal age to buy tobacco...

BY MD Anderson Staff

A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy...

BY Leslie Loddeke

Stories of immunotherapy’s success against metastatic melanoma in patients such as former President Jimmy Carter are well publicized, but...

BY Ron Gilmore

The biopharmaceutical drug blinatumomab is more effective for the treatment of relapsed or treatment-resistant acute lymphoblastic leukemia...

BY Laura Sussman

An advanced form of image-guided radiation therapy known as intensity modulated proton therapy (IMPT) has shown early promise for the treatment...

BY Scott Merville

Extensive genomic analysis led by MD Anderson researchers has opened new avenues to explore in the treatment of a rare and tenaciously lethal...

BY Scott Merville

International recognition continues to accumulate for Jim Allison, Ph.D., for opening up an entirely new way to treat cancer by freeing the...

BY Scott Merville

Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies...

BY Ron Gilmore

When triple-negative breast cancer is still in its earliest, pre-cancerous stages, the tumor suppressor miRNA-29c becomes progressively deactivated...

BY Scott Merville

Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly aggressive cell...

BY Laura Sussman

A new study from MD Anderson finds that women with early-stage breast cancer who had an intermediate risk recurrence score (RS)...

BY Scott Merville

Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic...

BY Ron Gilmore

Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a new way to kill lung cancer while doing minimal harm to normal cells...

BY Ron Gilmore

UBE20, a gene found on chromosome 17, may play a role in breast and prostate tumor formation, MD Anderson researchers found in a recent study...

BY Laura Sussman

For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone maintenance...

BY Ron Gilmore

Cyclin E, a protein important for DNA replication, is present in various forms of cancer in high levels. Overexpression of cyclin E correlates...

BY Clayton Boldt, Ph.D.

Researchers in MD Anderson’s Center for Energy Balance in Cancer Prevention and Survivorship are using mobile technology to learn what motivates...

BY Clayton Boldt, Ph.D.

Major innovations in cancer prevention, screening and treatment continue to develop at a rapid pace, especially through research initiatives...

BY Ron Gilmore

Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known...

BY Laura Sussman

Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the other breast, according...

BY Ron Gilmore

MD Anderson Cancer Center and Guardant Health recently announced a multi-year partnership designed to more quickly make comprehensive liquid...

BY Clayton Boldt, Ph.D.

As national vaccination rates for the human papillomavirus (HPV) remain low, MD Anderson Cancer Center has again united with the...

BY Clayton Boldt, Ph.D.

MD Anderson Cancer Center fully supports the proposed rule by the Food and Drug Administration (FDA) to limit a known carcinogen in finished...

BY Scott Merville

Bladder cancer patients with advanced disease have a new option for treatment after the Food and Drug Administration (FDA) this week approved...

BY MD Anderson staff

World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through prevention...

BY Laura Sussman

In a pilot study conducted at MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved...

BY Laura Sussman

In the first study evaluating patient-reported cosmetic outcomes in older women with breast cancer, MD Anderson researchers found that...

BY Ron Gilmore

The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival...

BY MD Anderson staff

In the modern world of biomedical research, collaborations between academic institutions and pharmaceutical and biotech companies have become...

BY Clayton Boldt, Ph.D.

Certain quality-of-life factors, such as pain and anxiety, have a significant impact on the likelihood of endometrial cancer survivors to...

BY Ron Gilmore

A study by MD Anderson researchers is shedding new light on how the protein PD-L1 suppresses the immune system, which may help scientists...